AngioDynamics (STU:UG2) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:UG2 AngioDynamics Inc STU:UG2
66 GF Score
Price €11.80
GF Value €8.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is AngioDynamics FFO per Share?

FFO per Share only applies to REITs.

STU:UG2
66GF Score
AngioDynamics Inc STU:UG2
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AngioDynamics (STU:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €11.80 is trading 41.8% above its estimated GF Value™ of €8.32. GuruFocus considers AngioDynamics to be Significantly Overvalued.

Key valuation signals for STU:UG2:

  • FFO per Share:
  • GF Value™: €8.32 vs. price of €11.80 (41.8% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the STU:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AngioDynamics Business Description

Other Exchanges ANGO:USA
Address 14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
66GF Score

Get the complete analysis for STU:UG2

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.80
Price
€8.32
GF Value